Early-Phase Trials in <i>Journal of Clinical Oncology</i>.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40403204.
- Also identified by DOI 10.1200/JCO-25-00548 and PMC identifier 12202164.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the article that accompanies this editorial, a well-designed trial confirmed that hearing can be protected through use of transtympanic thiosulfate injections in patients who receive high dose cisplatin with curative intent. In this editorial, members of the <i>Journal of Clinical Oncology</i> editorial board outline aspects of what constitutes high quality early phase trials with the goal of providing guidance for future JCO submissions.